skip to Main Content

February 18, 2020
Cure-Related Research Resources
A resource listing of articles, reports, websites, and ongoing clinical trials related to the research effort to cure HIV infection.

February 18, 2020
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).

February 14, 2020
An Activist’s Guide to the LAM Test
Publication
Tuberculosis (TB) is the number one killer of people living with HIV/AIDS, causing one in three of all AIDS-related deaths. People living with HIV are at increased risk of developing TB, and of dying from it—especially when they have advanced HIV disease, or AIDS. The LAM test can rapidly and…

February 5, 2020
Statement from the ACT NOW:END AIDS Coalition on President Trump’s State of the Union Commitment to Eradicate AIDS
Statement / Press
The ACT NOW:END AIDS Coalition, of which TAG is a founding member, released this statement today calling for the administration’s efforts to end the HIV epidemic to be rooted in fact, science, and sensible policies that are consistent with the stated goal of ending HIV.

February 3, 2020
Treatment Action Group Statement on the HVTN 702 HIV Vaccine Trial Results
Statement / Press
Treatment Action Group acknowledges with profound disappointment today’s announcement that the HIV Vaccine Trials Network HVTN 702 study did not demonstrate efficacy in preventing HIV acquisition.

January 31, 2020
Letter to USPTO Opposing Gilead’s Patent Term Extension Request for TAG
Letter / Comment
Treatment Action Group (TAG) joined 36 other organizations who signed on to this letter to the US Patent and Trademark Office (USPTO), opposing Gilead’s request for a patent term extension for tenofovir alafenamide (TAF). The letter also supports a recent petition submitted by PrEP4All, based on evidence that Gilead intentionally…

January 24, 2020
TAG Comment on the Trans-NIH Strategic Plan Goals for Sexual & Gender Minority (SGM) Health Research
Letter / Comment
TAG submitted this public comment in response to a Request for Information on the Development of the Fiscal Year 2021-2025 Trans-NIH Strategic Plan for Sexual & Gender Minority Health Research, affirming the need for a research agenda that will best address HIV, TB, and HCV among LGBTQ+ communities and incorporate…

January 22, 2020
Good COPs or Bad COPs: Promoting Interventions for Coinfections and AIDS in 2020 PEPFAR Country Operational Plans (COPs)
Webinar / Presentation
On January 22, 2020, Treatment Action Group (TAG), Médecins Sans Frontières (MSF) Access Campaign, Health GAP, IMPAACT4TB, and AVAC presented this webinar on how to engage in PEPFAR COPs advocacy. Materials are online now.

January 9, 2020
After Cuomo Speech, NY Health Orgs Including TAG Warn that Governor’s Health Plan Falls Short
Statement / Press
TAG, as part of the Save NY Public Health Campaign, called out Governor Cuomo’s recently announced Medicaid cuts and other failures to adequately address health and health equity in his January 8, 2020 “State of the State” address.

January 6, 2020
Open Letter: Time to Lower the Price of Xpert Cartridges to $5
Letter / Comment
TAG joined 156 organizations and individuals to demand that Cepheid lower the price of Xpert tests for TB, HIV, HCV and other diseases to improve access to rapid, accurate diagnostic testing.

Back To Top